Shalini Sharp
Overview
Shalini Sharp received an average of $2M in total compensation, including $384K in salary, at Ultragenyx Pharmaceutical from 2012 to 2019. Shalini Sharp also received an average of $433K at Agenus from 2006 to 2012.
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Executive Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Senior Vice President
Ultragenyx PharmaceuticalChief Financial Officer and Senior Vice President
AgenusFormer Vice President and Chief Financial Officer
AgenusFormer Vice President and Chief Financial Officer
Source: SEC filings on April 29, 2020, April 22, 2019, April 27, 2018, April 28, 2017, April 18, 2016, May 23, 2014, April 23, 2013, April 24, 2012, May 3, 2011, March 25, 2010, and April 27, 2009.
Related executives
We found 24 more executives who work or worked at Ultragenyx Pharmaceutical and Agenus.
Garo Armen
Agenus
Chief Executive Officer
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President, Translational Sciences
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
Jennifer Buell
Agenus
Chief Operating Officer
Evan Kearns
Agenus
General Counsel
Wladimir Hogenhuis
Ultragenyx Pharmaceutical